Pharmacoepidemiological research is integrated in work on variation in care and absolute CVD risk assessment and management. More targeted research, data integration and methodological developments have been part of the Centre of Research Excellence in Medicines and Ageing (CREMA). Current work in this area also includes:

• Optimising medication use for prevention of CVD events

• Investigation of novel anticoagulant use in Australia

• Opioid use

• Relation of CVD medications to lower urinary tract symptoms.

• High risk prescribing in older Australians

• Factors associated with home medicine review